简体中文

Professionals

Gu LongPartner

Tel::
+86 21 2415 5712
Fax:
+86 21 2422 4800
Email:
gulong@anjielaw.com
Expertise:
Mergers & Acquisitions, Private Equity and Venture Capital, Foreign Direct Investment, Healthcare and Life Science
Information
    Mr. Gu’s practicing areas are cross border acquisitions, PE&VC, FDI and JV, healthcare and life science, real estate, and general corporate.  In the area of mergers and acquisitions, Mr. Gu represented Takata, DHL, Continental, Eurazeo, LaSalle, Farfetch, Bank of China Investment Group, UOL, Park Place Real Estate, Shanghai Pharma, and etc. on their global or cross border equity and assets transfer deals.  In the area of PE&VC, Mr. Gu not only represented industry investors on their strategic investment projects, but also assisted various investment funds in their equity investment deals, including 5Y Capital, Matrix, Eli Lilly Asia Fund, Shanghai Healthcare Industry Investment Fund, FountainVest Partners, Forebright Capital, Navi Capital, Starcrest Fund, GP Capital, and etc.
     
    Mr. Gu has rich experiences in the sector of healthcare and life science, in recent years, he delivered many acquisition and investment transactions, license-in and license-out deals, and large-scale marketing and distribution collaboration projects in this sector.  Mr. Gu is also specialized in real estate acquisition and investment, and has represented many investment funds or multinational companies in their commercial and logistic real estate acquisition projects.
     
    Prior to his joining AnJie as a partner, Mr. Gu had served with the other two top-level PRC law firms for a long time, and acted as an Of Counsel in one of them.
     
    Working Language
    Mandarin, English

    Education
    Mr. Gu graduated from ECUPL with LLM degree.
     
    Admissions
    People’s Republic of China


Work Highlights

  1. Mergers & Acquisitions
  • Represented Takata, one of the world’s largest airbag maker, on its global sale of assets and equity interests to Joyson Electronic Corporation with the total transaction amount of $1.588 billion;
  • Represented Farfetch, a leading global e-commerce platform in the luxury fashion industry, on its assets acquisition of the luxury goods business of JD.com and its strategic cooperation deal with JD. com by obtaining “Level 1” entry point on JD APP;
  • Represented DHL for its acquisition of DHL Shenyang Logistics Park and the subsequent sale deal with Blackstone, with the aggregate transaction amount of RMB350 million;
  • Represented LaSalle, a leading real estate investment management firm, for its acquisition of logistic real estate assets package from CITIC, with the total transaction amount of RMB760 million;
  • Represented Park Place Group for its sale of Chongqing Park Place Plaza, with the transaction amount of RMB1.9 billion;
  • Represented Bank of China Group Investment Limited for its acquisition of 50% equity interests in Wanchuang Center from Vanke Group and a strategic collaboration relationship between the parties, with the transaction amount of RMB820 million;
  • Represented Bank of China Group Investment Limited for its acquisition of 100% equity interests in Matsunichi Dingsheng Mansion located in Shenzhen city, with the transaction amount of RMB700 million;
  • Represented UOL, a Singapore listed company group, for its sale of project company of Suzhou Pan Pacific Hotel, with the transaction amount of RMB450 million;
  • Represented Eurazeo, a France headquartered private equity investment fund for its acquisition of a food additives manufacturing enterprise in Nanchang;
  • Represented Parallels Holdings Ltd, a global leading software and service provider for desktop and remote application server solutions, on the PRC legal matters for its global business sale transaction with Coreal Corporation, with the global deal amount of around $135 million;
  • Represented Lohmann & Rauscher GmbH, a leading Germany medical products supplier, on the PRC legal matters related to its global acquisition of a compression stocking (medical device) manufacturer;
  • Represented Shanghai Pharma Group for its offshore acquisitions of medical equipment manufacturing and sales companies in the United States;
  • Represented Shanghai Medical Instruments Co., Ltd for its acquisition of a dental medical instrument manufacturing enterprise in Finland;
  • Represented Shanghai Pudong Technology Investment Co., Ltd for its offshore acquisition of a digital baseband R&D company in Korea.
 
  1. PE&VC
  • Represented many investment funds including 5Y Capital, Eli Lilly Asia Fund, Shanghai Healthcare Industry Investment Fund, FountainVest Partners, HM Capital, Longhill Capital, Forebright Capital, Navi Capital, Starcrest Fund, GP Capital, Hony Fund in their various onshore and offshore equity investment projects;
  • Represented Decathlon for its equity investment into a sports watch manufacturing company, and assisted the target company in its complicated pre-closing restructuring; 
  • Represented Xiaozhu APP in its strategic equity financing deals with Feizhu;
  • Represented Media Tek. Inc in its strategic investment into Vanchip;
  • Represented Changchun High-Tech Industry (Group) Co., Ltd. in its dual equity investments into the US and domestic affiliated companies engaged in Covid-19 vaccine R&D activities;
  • Represented one of Continental group’s JV company in China for its receiving strategic investment from China Unicom and CITIC Capital.
  • Represented Molbase, an integrated chemicals transaction platform, for its series B, series C and series D financing deals, with onshore and offshore dual financing structure;
  • Represented CrossBar to receive equity investment from SAIC with the investment amount of USD60 million.
 
  1. Healthcare and Life Science
  • Provided legal advice services for Boehringer Ingelheim’s human drugs animal health, and health management departments;
  • Provided legal advice services for GSK’s drugs, vaccines, and medical departments;
  • Provided legal advice services for Abbott’s nutrition, drugs and medical devices departments;
  • Provided legal advice services for MSD’s drugs and medical device departments;
  • Provided legal advice services for Sanofi’s drugs and medical device departments;
  • Represented Taikang Insurance Group in its branding license-in and strategic cooperation with Mount Sinai Medical Canter, a renowned US medical group;
  • Represented Shanghai Pharma Group for its conclusion of many license-in deals with different types of entities (including domestic innovative drugs R&D company, public research institute, and the US medicine college) to conclude technology license and development cooperation transactions, among of which, some project’s fixed milestone payment price (excluding royalties) will be around RMB1 billion;
  • Represented Shanghai Industrial Investment Group on its investment of several medical institutions, and to conclude entrust management collaboration with public-owned medical institutions;
  • Represented a Korean company group’s JV enterprise in China on its license-in deals regarding two IVD products (medical instruments) from its Korean partners;
  • Represented Hanhui Pharma on its several exclusive distribution and marketing collaborations regarding medical instrument products.
 
  1. FDI & JV
  • Represented Boehringer Ingelheim on its jointly establishment of a veterinary vaccines production base in Xi’an city;
  • Represented Continental Group for its several FDI and JV projects in China;
  • Represented DHL for a HK JV project with the target asset of a logistic industry park in Suzhou, and provided daily legal services for DHL’s logistic real estate department;
  • Represented Lear Corporation for its green investment and JV projects, and provided daily legal services in respect of labor, contractual disputes, and etc
  • Provided legal advices to Prudential, a global leading financial group, for its planned securities investment consultancy business in China.
 
  1. General Corporate
Mr. Gu is also serving or has served as daily advisors for manty enterprises, providing services in relation to major business cooperation projects, daily contracts review, commercial lease, labor, foreign exchange, IP protection, individual information protection, antitrust, antibribery, and regulatory matters on certain industries. 
 
The clients that he served with include MSD, Sanofi, GSK, Boehringer Ingelheim, Continental, DHL, Herbalife, Prudential, Farfetch, Brita, Avon, Lear Corporation, Honeywell, Schiesser, and etc.

Beijing Office

19/F, Tower D1, Liangmaqiao Diplomatic Office Building, No. 19 Dongfangdonglu, Chaoyang District, Beijing 100600

Tel:+86 10 8567 5988

Fax:+86 10 8567 5999

Shanghai Office

28/F, K.Wah Center,
No. 1010 Huaihai Road (M), Shanghai 200031

 

Tel:+86 21 2422 4888

Fax:+86 21 2422 4800

Shenzhen Office

38/F, Tower 3, Kerry Plaza,
No. 1-1 Zhongxinsi Road, Futian District, Shenzhen 518041

Tel:+86 755 8285 0609

Fax:+86 755 8285 0605

Follow us:

WeChat sweep
© 2016 - Copyright ANJIE - All Rights Reserved Designed by GreatMo